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One-Pot Synthesis of Highly Emissive Dipyridinium
Dihydrohelicenes
Amedeo Santoro*[a], Rianne M. Lord[a], Jonathan J. Loughrey[a], Patrick C. McGowan[a],
Malcolm A. Halcrow*[a], Adam F. Henwood[b], Connor Thomson[b] and Eli Zysman-Colman*[b]
Abstract: Condensation of a pyridyl-2-carbaldehyde derivative with
2-(bromoethyl)amine hydrobromide affords tetracyclic pyrido[1,2-
a]pyrido[1',2':3,4]imidazo-[2,1-c]-6,7-dihydropyrazinium dications in
excellent yields. Crystal structures and NOE data demonstrate the
helical character of the dications, the dihedral angles between the
two pyrido groups ranging from 28-45°. An intermediate in the
synthesis was also characterized. A much brighter emission
compared to literature helicenes has been found, with quantum
yields as high as 60% in the range of 460-600 nm. Preliminary
cytotoxicity studies against HT-29 cancer cells demonstrated
moderate-to-good activity, with IC50 values 12-30x that of cisplatin.
Helical poly-aromatic compounds (helicenes) are of intense
current interest.[1-3] Apart from the synthetic challenges involved
in preparing and resolving such compounds,[1,2,4] they are useful
auxiliary groups for asymmetric reactions and chiral catalysis.[3,5]
Helicenes and their derivatives can be chiral components in self-
assembly systems[1,3,6] and macromolecular materials,[3,7] while
many helicenes are fluorescent, with a chiral emission when
optically pure. Moreover, helicenes containing quinone,[4]
pyridinium[8–10] or thieno[11] fragments, or an appended metal
ion,[12] are redox-active and therefore switchable. This has led to
the development of organic light-emitting diodes (OLEDs) and
other chiroptical devices based on helicene fluorophores.[3,13]
The synthesis of pyrido[1,2-a]pyrido[1',2':3,4]imidazo-[2,1-c]-
6,7-dihydropyrazinium dibromide (1Br2, Scheme 1) by an acid-
catalysed reaction of pyridine-2-carboxaldehyde with (2-
bromoethyl)amine was first reported by Glover et al. in 1969.[14]
They proposed a mechanism for the transformation,[15] and
described the reactivity of 1Br2 towards basic hydrolysis and
hydrogenation. We fortuitously prepared 1Br2 during our studies
of heterocyclic chelate ligands for transition ions,[16] and report
now a more detailed study of this [4]-helical heterocycle and its
derivatives. While no more detailed structural or physical data
from 1Br2 have been reported so far, we note its relationship to
diquat helicene derivatives,[8–10] some of which exhibit
particularly favorable chiroptical properties.[9]
Scheme 1. Compounds referred to in this work.
As previously described,[14] reaction of pyridine-2-
carboxaldehyde with (2-bromoethyl)amine hydrobromide in
equimolar ratios in THF at room temperature affords 1Br2 as a
brown precipitate in good yield. The freshly prepared precipitate
is analytically pure, but can be recrystallized from ethanol/water
to afford monohydrate crystals 1Br2Â+2O. Treatment of aqueous
1Br2 with excess NH4PF6 precipitates 1[PF6]2, which is more
soluble in organic solvents. Repeating the procedure using 6-
methylpyridine-2-carboxaldehyde, quinoline-2-carboxaldehyde
or 6-(2-thienyl)-pyridine-2-carboxaldehyde afforded the
disubstituted derivatives 3[PF6]2, 5[PF6]2 and 6[PF6]2
respectively. More forcing conditions were needed to push these
reactions to completion, however, and the 2-(2-bromoethyl)-3-
(pyridin-2-yl)imidazo-[1,5-a]-pyridinium intermediates 2[PF6] and
4[PF6] were also isolated from such reactions performed at room
temperature. While 2[PF6] was obtained as a pure solid, 4[PF6]
was always contaminated with 5[PF6]2 and was purified for
characterization by a Pasteur separation. Hence, a wider
physicochemical study of that compound was not undertaken.
Heating 2[PF6] and 4[PF6] in DMF at 100 °C caused their
stoichiometric conversion to 3[PF6]2 and 5[PF6]2 by 1H NMR.[15]
Single crystal X-ray structure determinations of 1Br2Â+2O;
3[PF6]2, 4[PF6], 5[PF6]2 and 6[PF6]2Â&+3OH confirmed their
respective connectivity (Fig. 1). The metric parameters within the
tetracyclic framework are consistent with the tautomeric
structures shown, with clear single/double bond length
alternation in the imidazo[1,5-a]pyridinium fragments.[17] The
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tetracyclic dications all adopt helical conformations with the
degree of helicity, as measured by the dihedral angle between
the two pyrido rings (Z), being:
12+ [Z = 27.64(6)°] < 32+>@§
62+ [37.19(8)°] < 52+ [45.23(4)°]
This non-planarity reflects an intramolecular contact between the
H atoms bound to pyridinium C3 and imidazo[1,5-a]pyridinium
C5 (C(5) and C(14) in Fig. 1), which are 2.19 Å apart in
1Br2Â+2O.[18] This steric repulsion is exacerbated in 32+, 52+ and
62+, which have substituents at the imidazo[1,5-a]pyridinium C5
position. Only 3[PF6]2 crystallizes as optically pure helical
molecular crystals, in a chiral space group. The crystal
examined has P (') helicity, but equal numbers of P- and M-
helical crystals are present in the bulk sample. The other three
dications form racemate crystals, in centrosymmetric space
groups. Most of the helicity is generated by rotation about the
&í&ERQG LQ WKHGLK\GURS\UD]LQLXPULQJ)LJDOWKRXJK
a sterically-induced bending of the conjugated imidazo[1,5-
a]pyridinium fragment is also evident, particularly in 3[PF6]2. The
conformational strain implied by this increased helicity accounts
for our isolation of 2[PF6] and 4[PF6], and the need for forcing
conditions to complete the synthesis of 3[PF6]2 and 5[PF6]2.
Consistent with that, the quinolyl and imidazo[1,5-a]quinolinium
groups in 4[PF6] are close to perpendicular [Z = 78.27(3)°],
reflecting the relief of steric congestion between these groups by
IUHHURWDWLRQDERXWWKH&í&ERQG[17] The retention of these
helical conformations in CD3CN solution was confirmed by
NOESY analyses, which demonstrated strong NOE
enhancements between the pyridinium H3 atom and either the
imidazo[1,5-a]pyridinium H5 atom (1[PF6]2), or the methyl group
at that position (3[PF6]2).[17]
Figure 1. Top: view of the 12+ dication in the crystal structure of 1Br2Â+2O.
Thermal displacement ellipsoids are set at 50 %. Bottom: space-filling view of
12+, showing the intramolecular steric clash that gives rise to the helicity. The
view is along the C(7)–N(8) bond.[17]
Polyaromatic dyes can be DNA intercalators, which bind
between stacked base pairs in the DNA double helix.[19] Since
DNA intercalators can inhibit nucleic acid synthesis in vivo and
are therefore cytotoxic,[20] a preliminary cytotoxicity study was
performed by screening 1Br2Â+2O, 1[PF6]2, 2[PF6] and 5[PF6]2
against HT-29 (human colon adenocarcinoma) cancer cells. The
salts 1Br2 and 1[PF6]2 exhibit moderate cytotoxicities against
this cell line, compared to a cisplatin standard measured under
the same conditions (Table 1). Their identical IC50 values imply
that the counterions Brí and PF6í have no influence on cell
viability. The other two compounds show improved IC50 values,
of ca. 10x higher than cisplatin. This might be attributed to
different factors in the two compounds. First is the
conformational flexibility of 2+, whose pyridinium and imidazo-
[1,5-a]pyridinium groups can rotate freely with respect to each
other. That will allow 2+ to adjust its conformation in response to
the steric environment about the DNA nucleobase stacks.
Second, is the extended conjugation of the quinolinium groups in
5[PF6]2, which increases its hydrophobicity and promotes strong
intercalative S–S interactions with the DNA bases.
Table 1. Cytotoxicity data for compounds in this work, and a cisplatin
standard, against the HT-29 cancer cell line.
Compound IC50 (PM) Compound IC50 (PM)
1Br2Â+2O 107±3 2[PF6] 64±1
1[PF6]2 110±2 5[PF6]2 44±1
Cisplatin 3.6±0.2
Aside from their biological activity, these compounds also
demonstrate interesting photophysical and electrochemical
properties (Table 2, Fig. 2).[8,10] Assignment of their UV/vis
absorption bands is hindered by limited literature precedent.[8,9]
However, based on their energies, we have tentatively ascribed
the high energy bands (270-350 nm) of these compounds as
typical S–S* localized transitions, while the lower energy bands
are plausibly charge transfer (CT) transitions between the
charged pyridinium and imidazolium rings.
Figure 2. UV/vis spectra of 1Br2 (Ƒ), 1[PF6]2 ({), 2[PF6] (U), 3[PF6]2 (),
5[PF6]2 (z) and 6[PF6]2 (S) in MeCN at 298 K.
Table 2. Photophysical[a] and electrochemical[b] data for the compounds in this work.
Compound 1Br2 1[PF6]2 2[PF6] 3[PF6]2 5[PF6]2 6[PF6]2
Omax [nm]
(Hmax [103 Mícmí])
303 (3.27)
315 (3.47)
329 sh
384 sh
406 (16.4)
303 (3.34)
315 (3.34)
329 sh
387 sh
406 (21.5)
291 (13.2)
299 (13.2)
312 sh
326 sh
415 (0.69)
275 (5.11)
315 (4.16)
331 sh
395 sh
415 (23.4)
284 (23.0)
313 (9.62)
329 sh
439 sh
464 (27.3)
297 (12.7)
348 (11.8)
439 (12.3)
Oem [nm] 467 469 476 481 545 599
)PL [%] 33 42 29 22 60 0.2
We [ns] 3.84 3.99 3.98 4.25 6.78 6.60
E1½ [V] ('ES>P9@ í í í[c] í[c] í[c] í[c]
E2½ [V] ('Ep [mV]) í í  í í[c] í[c]
[a]In deaerated acetonitrile at 298 K. Quinine sulfate was used as the reference (ĭPL = 54.6% in 0.5 M H2SO4 at 298 K)[22] in all cases except
for 6[PF6]2, for which [Ru(bpy)3][PF6]2was used (ĭPL = 9.5% in deaerated acetonitrile at 298 K).[23] [b]Measurements were performed at 100
mV sí in deaerated MeCN solution at 298 K using Fc/Fc+ as an internal standard, and are referenced with respect to SCE (Fc/Fc+ = 0.38 V
in MeCN). [c]Irreversible process, Epc value quoted.
As might be expected, changing the counterion from 1Br2 to
1[PF6]2 causes very little change in the absorption spectra. At
high energies, there are multiple bands or shoulders (303, 315
and 329 nm), which demonstrate virtually identical absorptivities
regardless of the counter ion. Similarly, at lower energies (384-
387 and 406 nm) the form of the spectra is unchanged, although
the absorptivity observed for 1Br2 in this part of the spectrum is
slightly lower than for 1[PF6]2. The methyl substituents in 3[PF6]2
do not appreciably alter the spectra compared to 1[PF6]2, with
only the CT band undergoing a small 534 cm–1 red-shift with a
moderate increase in absorptivity. This red-shift, invoked by the
electron-donating nature of the methyl groups, points to
localisation of the HOMO on regions of the molecule adjacent to
the charged nitrogen atoms. This is supported by the greater
red-shift of the CT band (1851 cm–1 compared to 1[PF6]2)
induced by the more electron-donating 2-thienyl groups of
6[PF6]2. The extended aromaticity in 5[PF6]2 pushes the CT
band even more to the red, by 3079 cmí compared to 1[PF6]2.
While the CT bands vary significantly based on the
aromaticity and substituents of the dihydrohelicenes, the high
energy bands are largely unaffected. The only noticeable
changes come with 5[PF6]2, whose extended aromaticity
increases the overall absorptivity, and with 6[PF6]2 which
demonstrates an additional ʌ-ʌ* transition at 348 nm associated
with the 2-thienyl units.
The ring-opened intermediate 2[PF6] has no enforced
coplanarity of the pyridyl and imidazolyl rings. As a result, the
only pronounced bands are the high energy S–S* transitions,
localized on the individual pyridyl and imidazolyl rings, which
show reasonably large absorptivities in the region of ~13000 M–
1cm–1; by comparison, the low energy pyridyl-imidazolyl CT
transition is poorly absorbing (<700 M–1 cm–1) since there is poor
orbital overlap between the two mutually orthogonal
heterocycles. Upon ring closure to generate 3[PF6]2, the
absorptivity drastically increases, indicating significantly
improved orbital overlap facilitating the CT transition.
Compounds 1Br2, 1[PF6]2, 2[PF6] and 3[PF6]2 are deep blue
emitters, while 5[PF6]2 and 6[PF6]2 are green-yellow and orange
in color, respectively (Table 2, Fig. 3). The emission spectra of
1Br2 and 1[PF6]2 overlap, indicating that the counterion plays no
role in the emission process. The methyl groups in 3[PF6]2
induce a small 532 cm–1 red-shift in Oem compared to 1[PF6]2,
supporting the assertion that they are primarily modulating the
electronics of the HOMO; a very large red-shift of 4629 cm–1
observed for 6[PF6]2, bearing electron donating 2-thienyl
substituents, is also consistent with this assignment. Extending
the aromaticity in 5[PF6]2 also red-shifts emission. Interestingly,
despite its only bearing one charged center, 2[PF6]
demonstrates similar photophysical properties to 3[PF6]2, with a
blue-shift of only 218 cm–1. All the compounds show emission
lifetimes in the nanosecond regime, which indicate fluorescence.
Compounds 1Br2, 1[PF6]2, 2[PF6] and 3[PF6] are the shortest, in
the range of 3.84-4.25 ns, while 5[PF6]2 and 6[PF6] are 6.60-
6.78 ns.
Figure 3. Normalized emission spectra of 1Br2 (Ƒ), 1[PF6]2 ({), 2[PF6] (U),
3[PF6]2 (), 5[PF6]2 (z) and 6[PF6]2 (S) in deaerated MeCN at 298 K.
Although a number of emissive helical cationic-type
molecules have been reported,[8,10,21] their ĭPL values were not
usually determined which makes comparisons difficult. However,
Clennan and co-workers recently reported a dicationic helicene,
which contained two N-methylated quarternary ammonium
centers, that emitted with ĭPL = 6.6 %.[10] In contrast, the
compounds in this work, whose quarternary N atom is contained
within an aliphatic heterocycle, are much brighter with ĭPL as
high as 60% in the case of 5[PF6]2. Here the brightness of the
emission is enhanced through rigidification of the
dihydrohelicene framework by the quinolinyl units. Only 6[PF6]2
was found to be poorly emissive, which we ascribe to a “loose
bolt” effect resulting from the large 2-thienyl units.
Finally, the relevant electrochemical data are summarized in
Table 2.[17] All compounds except for 2[PF6] show two quasi-
reversible or irreversible one-electron reduction steps, as has
been frequently observed for other dicationic heliquats.[9,10]
2[PF6] only shows a single poorly resolved reduction wave. No
oxidation waves were observed except in the case of 1Br2,
which was attributed to oxidation of bromide.
The reduction waves of 1Br2 and 1[PF6]2 are virtually
identical, as expected. Surprisingly, in spite of the small red-shift
in absorption and emission observed for 3[PF6]2, the first
reduction wave is 0.11 V lower than 1[PF6]2. The Epc values
PLUURU WKLV ZLWK WKH YDOXH DSSHDULQJ DW í 9 IRU 1Br2 and
1[PF6]2EXWDWí9IRU3[PF6]2. However, the second wave is
largely unchanged. 5[PF6]2, by virtue of its extended aromaticity,
sees a large anodic shift in both reduction waves. In comparison,
6[PF6]2 undergoes a more modest change, consistent with the
suggestion that the 2-thienyl groups are largely modulating the
electronics of the HOMO. Interestingly, the reduction potential
for 2[PF6] largely matches those of 1Br2, 1[PF6]2 and 3[PF6]2.
This suggests that the second reduction process observed for
the dicationic species is attributable to reduction of the
imidazolium moiety, and thus the first wave – which is not
observed for 2[PF6] – can be ascribed to reduction of the
pyridinium moiety.
In conclusion, a one-pot synthesis of a family of helical
dications has been reported. Solutions of 1[PF6]2-5[PF6]2 are
highly fluorescent, with emissions ranging from the blue to
orange. The emission from 6[PF6]2 was significantly weaker,
which was ascribed to increased non-radiative decay due to the
“loose bolt” effect of the pendant 2-thienyl units.
Experimental Section
Synthetic procedures and characterization data for all the compounds in
this work, as well as details of the instrumentation and procedures used
for the spectroscopic and electrochemical measurements and the crystal
structure determinations, are given in the Supporting Information.[17]
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